NMD Pharma

Showing 1 posts of 1 posts found.

NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment

September 27, 2023
Research and Development Musculo-skeletal disorder, NMD Pharma, clinical trial, spinal muscular atrophy

NMD Pharma has announced that the first patient has been dosed in its phase 2 clinical trial for its CIC-1 …

Latest content